Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Circulating proteomic patterns in AF related left atrial remodeling indicate involvement of coagulation and complement cascade.

Kornej J, Büttner P, Hammer E, Engelmann B, Dinov B, Sommer P, Husser D, Hindricks G, Völker U, Bollmann A.

PLoS One. 2018 Nov 29;13(11):e0198461. doi: 10.1371/journal.pone.0198461. eCollection 2018.

2.

CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis.

Pfeiler S, Thakur M, Grünauer P, Megens RTA, Joshi U, Coletti R, Samara V, Müller-Stoy G, Ishikawa-Ankerhold H, Stark K, Klingl A, Fröhlich T, Arnold GJ, Wörmann S, Bruns CJ, Algül H, Weber C, Massberg S, Engelmann B.

FASEB J. 2019 Feb;33(2):1860-1872. doi: 10.1096/fj.201800985R. Epub 2018 Sep 12.

PMID:
30207797
3.

A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes.

Engelmann BW, Hsiao CJ, Blischak JD, Fourne Y, Khan Z, Ford M, Gilad Y.

Sci Rep. 2018 Aug 14;8(1):12106. doi: 10.1038/s41598-018-30587-3.

4.

EML4-ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib.

Huang T, Engelmann BJ, Morgan RM, Absher KJ, Kolesar JM, Villano JL.

Cancer Chemother Pharmacol. 2018 May;81(5):965-968. doi: 10.1007/s00280-018-3571-2. Epub 2018 Apr 2.

PMID:
29610932
5.

Distinct Pathogenesis of Pancreatic Cancer Microvesicle-Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo.

Stark K, Schubert I, Joshi U, Kilani B, Hoseinpour P, Thakur M, Grünauer P, Pfeiler S, Schmidergall T, Stockhausen S, Bäumer M, Chandraratne S, von Brühl ML, Lorenz M, Coletti R, Reese S, Laitinen I, Wörmann SM, Algül H, Bruns CJ, Ware J, Mackman N, Engelmann B, Massberg S.

Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):772-786. doi: 10.1161/ATVBAHA.117.310262. Epub 2018 Feb 1.

PMID:
29419408
6.

High-Throughput Quantification of SH2 Domain-Phosphopeptide Interactions with Cellulose-Peptide Conjugate Microarrays.

Engelmann BW.

Methods Mol Biol. 2017;1555:375-394. doi: 10.1007/978-1-4939-6762-9_21.

PMID:
28092044
7.

Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model.

Pietzner M, Engelmann B, Kacprowski T, Golchert J, Dirk AL, Hammer E, Iwen KA, Nauck M, Wallaschofski H, Führer D, Münte TF, Friedrich N, Völker U, Homuth G, Brabant G.

BMC Med. 2017 Jan 9;15(1):6. doi: 10.1186/s12916-016-0770-8.

8.

Propagation of thrombosis by neutrophils and extracellular nucleosome networks.

Pfeiler S, Stark K, Massberg S, Engelmann B.

Haematologica. 2017 Feb;102(2):206-213. doi: 10.3324/haematol.2016.142471. Epub 2016 Dec 7. Review.

9.

From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research".

Cabrera-Fuentes HA, Aragones J, Bernhagen J, Boening A, Boisvert WA, Bøtker HE, Bulluck H, Cook S, Di Lisa F, Engel FB, Engelmann B, Ferrazzi F, Ferdinandy P, Fong A, Fleming I, Gnaiger E, Hernández-Reséndiz S, Kalkhoran SB, Kim MH, Lecour S, Liehn EA, Marber MS, Mayr M, Miura T, Ong SB, Peter K, Sedding D, Singh MK, Suleiman MS, Schnittler HJ, Schulz R, Shim W, Tello D, Vogel CW, Walker M, Li QO, Yellon DM, Hausenloy DJ, Preissner KT.

Basic Res Cardiol. 2016 Nov;111(6):69. Epub 2016 Oct 14. Review.

10.

Distinct surveillance pathway for immunopathology during acute infection via autophagy and SR-BI.

Pfeiler S, Khandagale AB, Magenau A, Nichols M, Heijnen HF, Rinninger F, Ziegler T, Seveau S, Schubert S, Zahler S, Verschoor A, Latz E, Massberg S, Gaus K, Engelmann B.

Sci Rep. 2016 Oct 3;6:34440. doi: 10.1038/srep34440.

11.

Thousands of novel translated open reading frames in humans inferred by ribosome footprint profiling.

Raj A, Wang SH, Shim H, Harpak A, Li YI, Engelmann B, Stephens M, Gilad Y, Pritchard JK.

Elife. 2016 May 27;5. pii: e13328. doi: 10.7554/eLife.13328.

12.

Effect of Experimental Thyrotoxicosis onto Blood Coagulation: A Proteomics Study.

Engelmann B, Bischof J, Dirk AL, Friedrich N, Hammer E, Thiele T, Führer D, Homuth G, Brabant G, Völker U.

Eur Thyroid J. 2015 Sep;4(Suppl 1):119-24. doi: 10.1159/000381769. Epub 2015 May 28.

13.

FDG PET/CT in cancer: comparison of actual use with literature-based recommendations.

Petersen H, Holdgaard PC, Madsen PH, Knudsen LM, Gad D, Gravergaard AE, Rohde M, Godballe C, Engelmann BE, Bech K, Teilmann-Jørgensen D, Mogensen O, Karstoft J, Johansen J, Christensen JB, Johansen A, Høilund-Carlsen PF; PET/CT Task Force of the Region of Southern Denmark.

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):695-706. doi: 10.1007/s00259-015-3217-0. Epub 2015 Oct 30.

14.

Application of immobilized synthetic anti-lipopolysaccharide peptides for the isolation and detection of bacteria.

Sandetskaya N, Engelmann B, Brandenburg K, Kuhlmeier D.

Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1639-45. doi: 10.1007/s10096-015-2399-5. Epub 2015 May 19.

PMID:
25987244
15.

Extracellular DNA and histones as thrombus stabiliser.

Engelmann B.

Thromb Haemost. 2015 Jun;113(6):1164. doi: 10.1160/TH15-05-0375. Epub 2015 May 7. No abstract available.

PMID:
25947938
16.

Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature.

Böckelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B.

Acta Oncol. 2015 Jan;54(1):5-16. doi: 10.3109/0284186X.2014.975839. Epub 2014 Nov 28. Review.

PMID:
25430983
17.

The development and application of a quantitative peptide microarray based approach to protein interaction domain specificity space.

Engelmann BW, Kim Y, Wang M, Peters B, Rock RS, Nash PD.

Mol Cell Proteomics. 2014 Dec;13(12):3647-62. doi: 10.1074/mcp.O114.038695. Epub 2014 Aug 18.

18.

Biological basis and pathological relevance of microvascular thrombosis.

Pfeiler S, Massberg S, Engelmann B.

Thromb Res. 2014 May;133 Suppl 1:S35-7. doi: 10.1016/j.thromres.2014.03.016.

PMID:
24759139
19.

Activators, therapeutics and immunity-related aspects of thrombosis.

Engelmann B, Spannagl M.

Thromb Haemost. 2014 Apr 1;111(4):568-9. doi: 10.1160/TH14-03-0203. Epub 2014 Mar 20. No abstract available.

PMID:
24651966
20.

A new approach to glycan targeting: enzyme inhibition by oligosaccharide metalloshielding.

Mangrum JB, Engelmann BJ, Peterson EJ, Ryan JJ, Berners-Price SJ, Farrell NP.

Chem Commun (Camb). 2014 Apr 21;50(31):4056-8. doi: 10.1039/c3cc49695c.

21.

Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.

Engelmann BE, Loft A, Kjær A, Nielsen HJ, Gerds TA, Benzon EV, Brünner N, Christensen IJ, Hansson SH, Holländer NH, Kristensen MH, Löfgren J, Markova E, Sloth C, Højgaard L.

Oncologist. 2014 Feb;19(2):164-72. doi: 10.1634/theoncologist.2013-0229. Epub 2014 Jan 22.

22.

Antidepressants and platinum drugs.

Engelmann BJ, Ryan JJ, Farrell NP.

Anticancer Res. 2014 Jan;34(1):509-16.

PMID:
24403509
23.

Positron emission tomography/computed tomography for optimized colon cancer staging and follow up.

Engelmann BE, Loft A, Kjær A, Nielsen HJ, Berthelsen AK, Binderup T, Brinch K, Brünner N, Gerds TA, Høyer-Hansen G, Kristensen MH, Kurt EY, Latocha JE, Lindblom G, Sloth C, Højgaard L.

Scand J Gastroenterol. 2014 Feb;49(2):191-201. doi: 10.3109/00365521.2013.863967. Epub 2013 Nov 29.

24.

Crossroads of coagulation and innate immunity: the case of deep vein thrombosis.

Schulz C, Engelmann B, Massberg S.

J Thromb Haemost. 2013 Jun;11 Suppl 1:233-41. doi: 10.1111/jth.12261. Review.

25.

Thrombosis as an intravascular effector of innate immunity.

Engelmann B, Massberg S.

Nat Rev Immunol. 2013 Jan;13(1):34-45. doi: 10.1038/nri3345. Epub 2012 Dec 7. Review.

PMID:
23222502
26.

SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome.

Liu BA, Engelmann BW, Jablonowski K, Higginbotham K, Stergachis AB, Nash PD.

Cell Commun Signal. 2012 Sep 14;10(1):27. doi: 10.1186/1478-811X-10-27.

27.

High-throughput analysis of peptide-binding modules.

Liu BA, Engelmann BW, Nash PD.

Proteomics. 2012 May;12(10):1527-46. doi: 10.1002/pmic.201100599. Review.

28.

The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction.

Liu BA, Engelmann BW, Nash PD.

FEBS Lett. 2012 Aug 14;586(17):2597-605. doi: 10.1016/j.febslet.2012.04.054. Epub 2012 May 5. Review.

29.

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

von Brühl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Köllnberger M, Byrne RA, Laitinen I, Walch A, Brill A, Pfeiler S, Manukyan D, Braun S, Lange P, Riegger J, Ware J, Eckart A, Haidari S, Rudelius M, Schulz C, Echtler K, Brinkmann V, Schwaiger M, Preissner KT, Wagner DD, Mackman N, Engelmann B, Massberg S.

J Exp Med. 2012 Apr 9;209(4):819-35. doi: 10.1084/jem.20112322. Epub 2012 Mar 26.

30.

The SH2 domain-containing proteins in 21 species establish the provenance and scope of phosphotyrosine signaling in eukaryotes.

Liu BA, Shah E, Jablonowski K, Stergachis A, Engelmann B, Nash PD.

Sci Signal. 2011 Dec 6;4(202):ra83. doi: 10.1126/scisignal.2002105.

31.

Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells.

Kabolizadeh P, Engelmann BJ, Pullen N, Stewart JK, Ryan JJ, Farrell NP.

J Biol Inorg Chem. 2012 Jan;17(1):123-32. doi: 10.1007/s00775-011-0836-1. Epub 2011 Sep 15.

32.

Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases.

Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, Konrad I, Kennerknecht E, Reges K, Holdenrieder S, Braun S, Reinhardt C, Spannagl M, Preissner KT, Engelmann B.

Nat Med. 2010 Aug;16(8):887-96. doi: 10.1038/nm.2184. Epub 2010 Aug 1.

PMID:
20676107
33.

SH2 domains recognize contextual peptide sequence information to determine selectivity.

Liu BA, Jablonowski K, Shah EE, Engelmann BW, Jones RB, Nash PD.

Mol Cell Proteomics. 2010 Nov;9(11):2391-404. doi: 10.1074/mcp.M110.001586. Epub 2010 Jul 13.

34.

Cellular phospholipid uptake: flexible paths to coregulate the functions of intracellular lipids.

Engelmann B, Wiedmann MK.

Biochim Biophys Acta. 2010 Jun;1801(6):609-16. doi: 10.1016/j.bbalip.2010.02.013. Epub 2010 Mar 11. Review.

PMID:
20226876
35.

Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation.

Schulz C, Leuschen NV, Fröhlich T, Lorenz M, Pfeiler S, Gleissner CA, Kremmer E, Kessler M, Khandoga AG, Engelmann B, Ley K, Massberg S, Arnold GJ.

Blood. 2010 May 20;115(20):4102-10. doi: 10.1182/blood-2009-07-230268. Epub 2010 Jan 27.

36.

Protein disulfide isomerase as a trigger for tissue factor-dependent fibrin generation.

Manukyan D, von Bruehl ML, Massberg S, Engelmann B.

Thromb Res. 2008;122 Suppl 1:S19-22. doi: 10.1016/S0049-3848(08)70013-6. Review.

PMID:
18691493
37.

Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation.

Reinhardt C, von Brühl ML, Manukyan D, Grahl L, Lorenz M, Altmann B, Dlugai S, Hess S, Konrad I, Orschiedt L, Mackman N, Ruddock L, Massberg S, Engelmann B.

J Clin Invest. 2008 Mar;118(3):1110-22. doi: 10.1172/JCI32376.

38.

Rafs constitute a nodal point in the regulation of embryonic endothelial progenitor cell growth and differentiation.

Bidzhekov K, Hautmann M, Semisch M, Weber C, Engelmann B, Hatzopoulos AK.

J Cell Mol Med. 2007 Nov-Dec;11(6):1395-407. doi: 10.1111/j.1582-4934.2007.00123.x.

39.

Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor.

Baumgärtner P, Geiger M, Zieseniss S, Malleier J, Huntington JA, Hochrainer K, Bielek E, Stoeckelhuber M, Lauber K, Scherfeld D, Schwille P, Wäldele K, Beyer K, Engelmann B.

J Cell Biol. 2007 Nov 19;179(4):793-804.

40.

Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.

Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, Markart P, Song Y, Tzima E, Kennerknecht E, Niepmann M, von Bruehl ML, Sedding D, Massberg S, Günther A, Engelmann B, Preissner KT.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6388-93. Epub 2007 Apr 3.

41.

Eosinophils are a major intravascular location for tissue factor storage and exposure.

Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, Albrecht S, Lohse P, Patel KD, Engelmann B.

Blood. 2007 Feb 1;109(3):995-1002. Epub 2006 Sep 26.

42.

Initiation of coagulation by tissue factor carriers in blood.

Engelmann B.

Blood Cells Mol Dis. 2006 Mar-Apr;36(2):188-90. Epub 2006 Feb 13. Review.

PMID:
16473535
43.

Functional characterization of serotonin receptor subtypes in human duodenal secretion.

Engelmann BE, Bindslev N, Poulsen SS, Larsen R, Hansen MB.

Basic Clin Pharmacol Toxicol. 2006 Feb;98(2):142-9.

44.

Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.

Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA, Ouwehand WH, Farndale R, Nieswandt B, Siess W.

FASEB J. 2005 Jun;19(8):898-909.

PMID:
15923400
45.

Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP).

Nakazawa F, Kannemeier C, Shibamiya A, Song Y, Tzima E, Schubert U, Koyama T, Niepmann M, Trusheim H, Engelmann B, Preissner KT.

Biochem J. 2005 Feb 1;385(Pt 3):831-8.

46.

Plasmalogens: targets for oxidants and major lipophilic antioxidants.

Engelmann B.

Biochem Soc Trans. 2004 Feb;32(Pt 1):147-50.

PMID:
14748736
47.

Platelet ADP receptors contribute to the initiation of intravascular coagulation.

Leon C, Alex M, Klocke A, Morgenstern E, Moosbauer C, Eckly A, Spannagl M, Gachet C, Engelmann B.

Blood. 2004 Jan 15;103(2):594-600. Epub 2003 Sep 11.

48.

Intravascular tissue factor pathway--a model for rapid initiation of coagulation within the blood vessel.

Engelmann B, Luther T, Müller I.

Thromb Haemost. 2003 Jan;89(1):3-8. Review.

PMID:
12540946
49.

Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets.

Müller I, Klocke A, Alex M, Kotzsch M, Luther T, Morgenstern E, Zieseniss S, Zahler S, Preissner K, Engelmann B.

FASEB J. 2003 Mar;17(3):476-8. Epub 2003 Jan 2.

PMID:
12514112
50.

Influence of immunosuppressive drugs on intestinal epithelial transport function.

Stockmann M, Engelmann BE, Langrehr JM, Neuhaus P.

Transplant Proc. 2002 Aug;34(5):1449-50. No abstract available.

PMID:
12176434

Supplemental Content

Loading ...
Support Center